Bank Of Montreal Corcept Therapeutics Inc Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bank Of Montreal holds 12,156 shares of CORT stock, worth $463,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,156

Previous 11,576 5.01%

Holding current value

$463,629

Previous $291,000 35.4%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $12,881 - $19,998	580 Added 5.01%	12,156 $394,000
Q1 2024 May 13, 2024	SELL	$21.1 - $27.46 $1,688 - $2,196	-80 Reduced 0.69%	11,576 $291,000
Q4 2023 Feb 08, 2024	BUY	$24.82 - $32.88 $19,185 - $25,416	773 Added 7.1%	11,656 $378,000
Q3 2023 Nov 01, 2023	SELL	$21.97 - $33.8 $466,686 - $717,979	-21,242 Reduced 66.12%	10,883 $296,000
Q2 2023 Aug 02, 2023	SELL	$21.44 - $25.15 $3.21 Million - $3.77 Million	-149,742 Reduced 82.34%	32,125 $714,000
Q1 2023 Jun 13, 2024	BUY	$19.2 - $24.47 $60,691 - $77,349	3,161 Added 27.31%	14,737 $319,000
Q4 2022 Feb 01, 2023	SELL	$19.95 - $29.96 $581,722 - $873,603	-29,159 Reduced 13.82%	181,867 $3.69 Million
Q3 2022 Nov 10, 2022	BUY	$24.7 - $29.12 $88,994 - $104,919	3,603 Added 1.74%	211,026 $5.85 Million
Q2 2022 Aug 11, 2022	BUY	$17.33 - $25.3 $3.14 Million - $4.58 Million	180,918 Added 682.58%	207,423 $5.26 Million
Q1 2022 May 12, 2022	SELL	$16.53 - $25.21 $23,108 - $35,243	-1,398 Reduced 5.01%	26,505 $643,000
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $138,817 - $189,474	-8,118 Reduced 22.54%	27,903 $544,000
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $37,884 - $43,370	-1,925 Reduced 5.07%	36,021 $731,000
Q2 2021 Aug 12, 2021	BUY	$19.97 - $24.43 $757,781 - $927,020	37,946 New	37,946 $846,000

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.08B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account